DATE18/03/2017
PLACESitges, Spain
Single agent therapy and BRCA1 Rosell R, MD, PhD
DATE10/03/2017 - 11/03/2017
PLACEEssen, Germany
Co-activation of STAT3 and the YAP1 pathway limits EGFR inhibitor response in EGFR-mutant NSCLC Rosell R, MD, PhD
DATE24/02/2017
PLACENobel Forum, Karolinska Institutet, Stockholm, Sweden
Compensatory signaling pathways in response to EGFR inhibitors in NSCLC Rosell R, MD, PhD
DATE27/01/2017 - 28/01/2017
PLACESantiago de Compostela, Spain
El nuevo rol de las plaquetas en cáncer de pulmón: de la coagulación al sequestro Rosell R, MD, PhD
DATE13/12/2016
PLACEBarcelona, Spain
